Simple spit test could predict prostate cancer risk in black, asian, and white men
NCT ID NCT06636526
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new saliva-based DNA test called i4i PRODICT® that estimates a person's future risk of prostate cancer. Researchers want to see if men of Black African/Caribbean, South Asian, and White backgrounds aged 40-55 will take the test and find it acceptable. The test looks at both common and rare genetic changes to classify men as high-risk or population risk, and those at high risk will be offered targeted screening.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
i4i PRODICT® test (saliva-based DNA test for genetic risk of prostate cancer)
What this could lead to
If successful, this test could help identify men at high risk for prostate cancer earlier, especially in ethnic groups that are often understudied.
What could go wrong
This is an early study focused on feasibility and uptake, not on proving the test prevents or detects cancer. The test may not accurately predict risk in all groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
RECRUITINGSutton, Surrey, SM2 5PT, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Royal Marsden Hospital
RECRUITINGLondon, SW3 6JJ, United Kingdom
Contact Email: •••••@•••••
-
The Royal Marsden Hospital
RECRUITINGSutton, SM2 5PT, United Kingdom
Contact Email: •••••@•••••